NPLATE 500 microgramos polvo para solución inyectable ( DrugBank: - )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
63	Idiopathic thrombocytopenic purpura	1

63. Idiopathic thrombocytopenic purpura

---

Clinical trials : 363 /  Drugs : 212 - (DrugBank : 43) / Drug target genes : 47 - Drug target pathways : 138

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2010-019987-35-ES (EUCTR)	22/09/2010	31/08/2010	Estudio de fase 2, intervencionista, de un solo brazo para describir la respuesta plaquetaria y las tasas de remisión de PTI en sujetos adultos con Púrpura Trombocitopénica Inmune que reciben Romiplostim.-------------------------------------------------------A Phase 2, Interventional, Single Arm Study Describing Platelet Responses and ITP Remission Rates in Adult Subjects with Immune Thrombocytopenia Purpura Receiving Romiplostim	Estudio de fase 2, intervencionista, de un solo brazo para describir la respuesta plaquetaria y las tasas de remisión de PTI en sujetos adultos con Púrpura Trombocitopénica Inmune que reciben Romiplostim.-------------------------------------------------------A Phase 2, Interventional, Single Arm Study Describing Platelet Responses and ITP Remission Rates in Adult Subjects with Immune Thrombocytopenia Purpura Receiving Romiplostim	Púrpura Trombocitopénica Inmune(Idiopática) (PTI) en adultos----------------------------------Adult immune thrombocytopenic purpura (ITP) MedDRA version: 12.1;Level: LLT;Classification code 10021245;Term: Idiopathic thrombocytopenic purpura	Trade Name: NPLATE 500 microgramos polvo para solución inyectable INN or Proposed INN: ROMIPLOSTIM Other descriptive name: ROMIPLOSTIM	Amgen Inc	NULL	Not Recruiting			Female: yes Male: yes	75	Phase 2	France;Czech Republic;Spain;Germany;United Kingdom;Italy